News

CEO Christophe Weber to retire from Takeda in June 2026 after 12 years; Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process ...
Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q1 2022 Earnings Conference Call July 30, 2021 6:00 AM ETCompany Participants. Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber ...
Takeda Pharmaceutical Company Limited (NYSE: ... CEO Christophe Weber on Q2 2022 Results - Earnings Call Transcript. Oct. 29, 2021 2:52 PM ET Takeda Pharmaceutical Company Limited ...
When Christophe Weber was appointed CEO of Takeda in 2014, he set out on a mission to transform the 240-year old Japanese pharmaceutical company into a major global player.
Takeda Pharmaceutical Co.’s shares might be trading at about half of their level before the $62 billion acquisition of Shire in 2018, ... Chief Executive Officer Christophe Weber said. ...
Takeda Pharmaceutical Company Limited (TKPYY) Proposed Acquisition of Shire PLC Group May 8, 2018 3:15 AM ET. Executives. Christophe Weber - President and CEO ...
Takeda Warns New Drugs at Risk If Countries Push Deep Price ... “If you push too much you reach a point where you’ll impact the ability to invest in R&D and innovate,” Christophe Weber, ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q1 2022 Results Conference Call July 28, 2022 6:00 AM ETCompany Participants. Ayako Iwamuro - IR Christophe Weber - President and CEO Andy Plump ...
Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q2 2021 Earnings Conference Call October 29, 2020 5:30 AM ETCompany Participants. Christopher O'Reilly - IR Christophe Weber - President, CEO ...
Takeda Pharmaceutical Company Limited. (NYSE:TAK) Q3 2022 Earnings Conference Call February 3, 2022 6:00 AM ETCorporate ParticipantsChristopher O’Reilly - ...
Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q3 2021 Earnings Conference Call February 4, 2021 6:00 AM ETCompany Participants. Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Conference Call May 11, 2022 6:00 AM ETCompany Participants. Ayako Iwamuro - IR Christophe Weber - CEO Andy Plump - R&D President ...